Abstract
Background:At EULAR 2017, we reported that the treatment of early rheumatoid arthritis (RA) patents by a low-dose and short-term glucocorticoid therapy (low and short GC) enabled earlier improvement and didn’t...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
